New drug combination attacks prostate cancer on two fronts to keep men healthy for longer 08 Jul 2021 Men with particularly aggressive prostate cancers can be treated more effectively by combining an existing targeted medicine, abiraterone, with a new experimental drug to block two of cancer’s growth signals at once, a major new trial shows. Find out more Show/Hide
AACR Annual Meeting 2021: Immunotherapy combination shows early promise in aggressive brain cancers 11 Apr 2021 Immunotherapy together with an experimental cancer drug could offer a new way of treating some patients with aggressive brain cancers, promising early results from a Phase I trial presented at the 2021 AACR conference suggest. Find out more Show/Hide
ESMO 2020: Two-pronged attack using new targeted drug could treat ‘addicted’ prostate cancers 21 Sep 2020 An experimental cancer drug used alongside targeted hormone treatment could treat an aggressive group of prostate cancers which have become ‘addicted’ to growth signals, a major phase III clinical trial has shown. Find out more Show/Hide